NRAS mutations lead to a substitution of the amino acids at positions G12 or G13 making NRAS insensitive to the inactivation by the Ras GTPase-activating proteins, or more common at position Q61, where Q61R is predominant in melanoma cells [81]. Here, NRAS is linked to melanoma.